Table 1: NMSC and melanoma IRs and 95% CIs per 100 patient-years by duration of exposure during cumulative ST and LTE periods of IV+SC abatacept (N=6028). IR=incidence rate; LTE=long-term extension; NMSC=non-melanoma skin cancer; ST=short term
Table 1: NMSC and melanoma IRs and 95% CIs per 100 patient-years by duration of exposure during cumulative ST and LTE periods of IV+SC abatacept (N=6028). IR=incidence rate; LTE=long-term extension; NMSC=non-melanoma skin cancer; ST=short term